← Back to home

LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED

Clinical trials for LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New vaccine combo tested in fight against advanced cervical cancer

Disease control Ongoing

This study is testing whether adding an experimental vaccine (PDS0101) to standard chemotherapy and radiation is safe for patients with locally advanced cervical cancer. The vaccine is designed to help the immune system target cancer cells linked to HPV. Researchers will enroll a…

Matched conditions: LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Feb 27, 2026 15:05 UTC

LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED

Get alerted when new LOCALLY ADVANCED CERVICAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED trials appear

New vaccine combo tested in fight against advanced cervical cancer